The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.

Immunoglobulin was obtained from the tumor cells of a patient with nodular lymphoma by hybridization to mouse myeloma cells. The human immunoglobulin secreted by these hybridoma cells was used as an immunogen to make murine monoclonal antibodies. Antibodies specific for idiotype, mu heavy chain and lambda light chain, were produced. One anti-idiotype antibody was used to document that idiotype-positive cells and low levels of 19S IgM idiotype were present in the patient's blood. The levels of each were found to correlate with the patient's disease activity. The monoclonal anti-idiotype was effective in eliminating idiotype-positive cells in vitro by solid phase absorption or by complement-mediated cytotoxicity. The anti-idiotype was also used to analyze the host's immunologic response to his own tumor idiotype. There was neither a detectable anti-idiotype antibody response produced in vivo nor a detectable population of T cells that expressed idiotype of could bind idiotype.

• Publication year

  1981

• Venue

  Journal of Immunology

• Publication date

  1981-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.126.6.2397PMID 6785351
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoclonal B-lymphocytes in peripheral blood of patients with plasma cell myeloma. Relation to activity of the disease.

  2009cited by this paper
• Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

  1980cited by this paper
• Immunoglobulin secretion by mouse X human hybridomas: an approach for the production of anti-idiotype reagents useful in monitoring patients with B cell lymphoma.

  1980cited by this paper
• Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.

  1980cited by this paper
• Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation

  1979cited by this paper
• Evidence that murine pre-B cells synthesise μ heavy chains but no light chains

  1979cited by this paper
• A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

  1979cited by this paper
• BCL1, a Murine Model for Chronic Lymphocytic Leukemia: Use of the Surface Immunoglobulin Idiotype for the Detection and Treatment of Tumor

  1979cited by this paper
• Shared idiotypes of human peripheral blood B and T lymphocytes.

  1979cited by this paper
• The lymphoid system. Its normal architecture and the potential for understanding the system through the study of lymphoproliferative diseases.

  1978cited by this paper
• A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics: correlation with clinical features.

  1978cited by this paper
• Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization.

  1978cited by this paper
• Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.

  1977cited by this paper
• Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target.

  1977cited by this paper
• The monoclonality of human B-cell lymphomas

  1977cited by this paper
• Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

  1977cited by this paper
• Idiotype‐bearing and antigen‐binding receptors produced by blood T lymphocytes in a case of human myeloma

  1977cited by this paper
• Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes

  1976cited by this paper
• Idiotypic analysis of lymphocytes in vitro. I. Specificity and heterogeneity of B and T lymphocytes reactive with anti-idiotypic antibody

  1976cited by this paper
• Effective radioiodination by lactoperoxidase and solubilisation of cell-surface proteins of cultured murine T lymphoma cells.

  1975cited by this paper
• Similar idiotypic specificity for the membrane IgD and IgM of human B lymphocytes.

  1975cited by this paper
• Antibody to a molecularly-defined antigen confined to a tumour cell surface

  1975cited by this paper
• Induction of T and B cell immunity by anti‐idiotypic antibody

  1975cited by this paper
• B-cell neoplasia in man.

  1974cited by this paper
• Use of the avidin-biotin complex for specific staining of biological membranes in electron microscopy.

  1974cited by this paper
• IDIOTYPIC UNIFORMITY OF CELL SURFACE IMMUNOGLOBULIN IN CHRONIC LYMPHOCYTIC LEUKEMIA

  1974cited by this paper
• Multiple myeloma and benign monoclonal gammopathy: differentiation by immunofluorescence of lymphocytes.

  1973cited by this paper
• IMMUNOGLOBULIN AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE AS MARKERS OF CELLULAR ORIGIN IN BURKITT LYMPHOMA

  1973cited by this paper
• Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases

  1973cited by this paper
• IDIOTYPIC DETERMINANTS OF IMMUNOGLOBULIN M DETECTED ON THE SURFACE OF HUMAN LYMPHOCYTES BY CYTOTOXICITY ASSAYS

  1972cited by this paper
• Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

  1962cited by this paper

• Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases

  2025cites this paper
• The Impact of the Hybridoma Technology on the R&D of Idiotypic Antibodies

  2021cites this paper
• Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies

  2020cites this paper
• Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.

  2017cites this paper
• Antibodies: At The Nexus of Antigens and Cancer Vaccines.

  2015cites this paper
• Translational Medicine in Action: Anti-CD20 Therapy in Lymphoma

  2014cites this paper
• Cancer Immunotherapeutics: Evolution of Monoclonal Antibodies to Peptide Immunogens

  2014cites this paper
• Introduction to monoclonal antibodies.

  2012cites this paper
• Transsexualism observed "

  2006cites this paper
• Biological therapy of cancer

  2005cites this paper
• Human tumor-associated antigens identified by monoclonal antibodies

  2004cites this paper
• Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.

  2001cites this paper
• The history of the development of vaccines for the treatment of lymphoma.

  2000cites this paper
• Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone.

  1998cites this paper
• Anti-Idiotypic Antibodies in HIV-Infected Patients to a Neutralizing Mab and its Complementarity Determining Regions

  1997cites this paper
• Biologic therapies for low-grade lymphomas.

  1993cites this paper
• Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells.

  1992cites this paper
• Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells

  1992cites this paper
• Interfaces of the yeast killer phenomenon.

  1991cites this paper
• Management of posterior uveal melanoma.

  1991cites this paper
• Anti-Idiotypic Tumor Vaccines

  1991cites this paper
• Current approaches to vaccine preparation.

  1990cites this paper
• Idiotipler ve Idiotip Ağlari

  1989cites this paper
• [Antibodies as antigens--idiotypes and idiotypic networks].

  1989cites this paper
• Use of anti-idiotypic antibodies to treat lymphoid tumors.

  1989cites this paper
• Monoclonal antibodies: A new class of reagents in cancer therapy

  1989cites this paper
• Secondary lymphomas: a review on lymphoproliferative diseases arising in immunocompromised hosts: prevalence, clinical features and pathogenetic mechanisms.

  1989cites this paper
• Clonal analysis of untreated non-Hodgkin's lymphoma utilizing immunoglobulin gene rearrangement and immunophenotype.

  1988cites this paper
• Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer‐associated antigens by anti‐idiotypic antibodies

  1988cites this paper
• Auto‐anti‐idiotypic antibodies in mice hyperimmunized with a chemically induced bladder carcinoma

  1988cites this paper
• Production of mouse monoclonal antibodies for the analysis of idiotypes in serum of patients with chronic lymphatic leukaemia

  1988cites this paper
• Human-Mouse Hybridoma Formation

  1987cites this paper
• In vitro tests that predict tumor-associated idiotype levels in the serum of patients with B cell lymphomas and leukemias.

  1987cites this paper
• Isolation of anti-idiotypic antibodies to T cells using an anti-framework determinant antibody.

  1987cites this paper
• Current concepts: immunology. Idiotypes and idiotypic networks.

  1987cites this paper
• Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically active monoclonal anti-idiotopes.

  1987cites this paper
• Cross-reactive variable-region associated epitopes of human IgG1 lambda paraprotein detected by a monoclonal antibody panel.

  1987cites this paper
• Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells.

  1987cites this paper
• Chronic leukemias: oncogenes, chromosomes, and advances in therapy.

  1986cites this paper
• Influence of avidity and idiotope recognition on the modulation of surface immunoglobulin on malignant human B cells by rat monoclonal anti-idiotype antibodies.

  1986cites this paper
• Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.

  1986cites this paper
• The human anti–myelin‐associated glycoprotein IgM system

  1986cites this paper
• Monoclonal immunoscintigraphy for the detection of primary colorectal cancers: A prospective study

  1986cites this paper
• Differentiation-linked gene rearrangement and expression in acute lymphoblastic leukaemia.

  1986cites this paper
• 8th Annual San Antonio Breast Cancer Symposium Biological therapy of cancer

  1986cites this paper
• Monoclonal Antibody Therapy of Cancer: Preclinical Models and Investigations in Humans

  1986cites this paper
• Differentiation-linked leukemogenesis in lymphocytes.

  1986cites this paper
• Preparation and properties of FabIgG, a chimeric univalent antibody designed to attack tumour cells

  1985cites this paper
• A clinical trial of anti-idiotype therapy for B cell malignancy.

  1985cites this paper
• Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies.

  1985cites this paper
• Treatment of Leukemia and Lymphoma with Biological Response Modifiers

  1985cites this paper
• Monoclonal Antibody Therapy for Patients with Leukemia and Lymphoma

  1985cites this paper
• Biological Approaches to the Therapy of Lymphoproliferative Diseases

  1985cites this paper
• Differences in "host infiltrates" among lymphoma patients treated with anti-idiotype antibodies: correlation with treatment response.

  1985cites this paper
• Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum liver enzyme levels and liver scan.

  1985cites this paper
• Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.

  1985cites this paper
• Monoclonal Anti-Idiotype Antibodies Against the Murine B Cell Lymphoma 38C13: Characterization and Use as Probes for the Biology of the Tumor In Vivo and In Vitro

  1985cites this paper
• Monitoring of a Human B Cell Lymphoma with Monoclonal Antiidiotype Antibodies

  1985cites this paper
• Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens

  1985cites this paper
• Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.

  1985cites this paper
• Heteroantibody duplexes target cells for lysis by cytotoxic T lymphocytes.

  1985cites this paper
• The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.

  1985cites this paper
• The use of monoclonal antibodies and flow cytometry to detect peripheral blood and bone marrow involvement of a diffuse, poorly differentiated lymphoma.

  1985cites this paper
• Detection of two distinct malignant B cell clones in a single patient using anti-idiotype monoclonal antibodies and immunoglobulin gene rearrangement.

  1985cites this paper
• 2 – Monoclonal Antibodies in the Diagnosis and Treatment of Cancer

  1984cites this paper
• Shared idiotypes among surface immunoglobulins in non-Hodgkin's lymphoma.

  1984cites this paper
• Idiotype network interactions in tumor immunity.

  1984cites this paper
• Production of large quantities of human immunoglobulin in the ascites of athymic mice: implications for the development of anti-human idiotype monoclonal antibodies.

  1984cites this paper
• Monoclonal antibody immunoscintigraphy for the detection of gastrointestinal tumours.

  1984cites this paper
• Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas.

  1984cites this paper
• Monoclonal antibodies: the possibilities for cancer therapy.

  1984cites this paper
• Nonsexual transmission of gonorrhea to a child.

  1984cites this paper
• Cellular DNA of human neoplastic B-cells measured by flow cytometry.

  1984cites this paper
• Mouse monoclonal antibodies against the idiotype of human B cell non‐Hodgkin lymphomas: production, characterization and use to monitor the progress of disease

  1984cites this paper
• Development and Use of Monoclonal Antibodies in the Treatment of Cancer

  1984cites this paper
• Chapter 22 – The Idiotype Network: Theoretical and Practical Implications for Autoimmune Disease

  1984cites this paper
• Biclonal B-cell lymphoma.

  1984cites this paper
• Human neoplastic B cells: monoclonal models of B-cell differentiation.

  1983cites this paper
• Determination of the optimal human cell lines for development of human hybridomas.

  1983cites this paper
• Treatment of a low grade T cell proliferation with monoclonal antibody.

  1983cites this paper
• Radioimmunodetection of cancer: problems and potential.

  1983cites this paper
• Immunostimulation in cancer patients.

  1983cites this paper
• Biology of disease. Endogenous control of the neoplastic process.

  1983cites this paper
• Strategy to Obtain Monoclonal Anti-Idiotype Antibodies

  1983cites this paper
• Monoclonal antibodies of hybridomas.

  1983cites this paper
• New developments in immunoperoxidase techniques and their application.

  1983cites this paper
• Immune guided missiles.

  1982cites this paper
• Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

  1982cites this paper